Control of IL-5 production by human helper T cells as a treatment for eosinophilic inflammation: Comparison of in vitro and in vivo effects between selective and nonselective cytokine synthesis inhibitors

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 1, 2000, Pages S58-S64

  Mori, Akio ^a   Kaminuma, Osamu ^a,b   Ogawa, Koji ^a,b   Nakata, Aya ^a,b   Egan, Robert W ^a,c   Akiyama, Kazuo ^a   Okudaira, Hirokazu ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^c MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Eosinophilic inflammation; T cell

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; INTERLEUKIN 5; NEUTRALIZING ANTIBODY; NONACTIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL CLONE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HELPER CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CLONE CELLS; CYCLOSPORINE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; MACROLIDES; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; TACROLIMUS;

EID: 0033941412     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.106775     Document Type: Article

References (49)

1. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol. 39:1986;177-253.
2. +) T cells and eosinophils in allergy and asthma. Am Rev Respir Dis. 145:1992;S22-6.
3. Ohnishi T, Kita H, Weiler D, Sur S, Sedgwick JB, Calhoun WJ. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis. 147:1993;901-907.
4. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC. Allergic and non-allergic asthmatics have distinct patterns of T cell activation and cytokine production in peripheral blood and bronchoalveolar lavage fluid. Am Rev Respir Dis. 146:1992;109-115.
5. Corrigan CJ, Haczku A, Engesaeth V, Doi S, Kikuchi Y, Takatsu K. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis. 147:1993;540-547.
6. + T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int Immunol. 7:1995;449-457.
7. Mori A, Kaminuma O, Suko M, Mikami T, Nishizaki Y, Ohmura T. Cellular and molecular mechanisms of IL-5 synthesis in atopic diseases: a study using allergen-specific human helper T cells. J Allergy Clin Immunol. 100:1997;S56-64.
8. Gulbenkian AR, Egan RW, Fernandez X, Jones H, Kreutner W, Kung T. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Respir Dis. 146:1992;263-266.
9. Mauser PJ, Pitman A, Witt A, Fernandez X, Zurcher J, Kung T. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis. 148:1993;1623-1627.
10. Kaminuma O, Mori A, Ogawa K, Naito K, Nakata A, Kikkawa H. Successful transfer of late-phase eosinophil infiltration in the lung by infusion of helper T cell clones. Am J Respir Cell Mol Biol. 16:1997;448-454.
11. Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med. 185:1997;2143-2156.
12. Schleimer PR. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis. 141:1990;S59-69.
13. Snyder DS, Unanue ER. Corticosteroids inhibit murine Ia expression and IL-1 production. J Immunol. 129:1982;1803-1805.
14. Vacca A, Martinotti S, Screpanti I, Maroder M, Felli MP, Farina AR. Transcriptional regulation of the interleukin-2 gene by glucocorticoid hormones. J Immunol. 265:1990;8075-8080.
15. Staynov DZ, Lee TH. Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in human peripheral blood mononuclear cells after activation with phorbol myristate acetate. Immunology. 75:1992;196-201.
16. Mori A, Kaminuma O, Suko M, Inoue S, Ohmura T, Hoshino A. Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids. Blood. 89:1997;2891-2900.
17. Alexander AG, Barnes NC, Kay AB. Trial of cyclosporin in cortico-steroid-dependent chronic severe asthma. Lancet. 339:1992;324-328.
18. Nakagawa H, Etoh T, Ishibashi Y, Higaki Y, Kawashima M, Torii H. Tacrolimus ointment for atopic dematitis. Lancet. 344:1994;883.
19. Schreiber SL. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 251:1991;283-287.
20. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today. 13:1992;136-142.
21. Riegel JS, Corthesy B, Flanagan WM, Crabtree GR. Regulation of the interleukin-2 gene. In: Kishimoto T, editor. Chemical immunology. Basel, Switzerland: Karger. 1992;266-298.
22. Mori A, Kaminuma O, Mikami T, Inoue S, Okumura Y, Akiyama K. Transcriptional control of IL-5 gene by human helper T cells: IL-5 synthesis is regulated independently from IL-2 or IL-4 synthesis. J Allergy Clin Immunol. 103:1999;S429-36.
23. + T cells is suppressed by FK506. J Immunol. 158:1997;3659-3665.
24. Okudaira H, Mori A, Suko M, Ito K. Selective suppression of IL-5 synthesis by OM-01. Int Arch Allergy Immunol. 113:1997;331-334.
25. Yuuki T, Okumura Y, Ando T, Yamakawa H, Suko M, Haida M. Cloning and expression of cDNA for the major house dust mite allergen Der f II in Escherichia coli. Agricultural and Biological Chemistry, 55:1991;1233-1238.
26. Mori A, Suko M, Kaminuma O, Inoue S, Ohmura T, Nishizaki Y. IL-15 promotes cytokine production of human helper T cells. J Immunol. 156:1995;2391-2405.
27. Mori A, Suko M, Tsuruoka N, Kaminuma O, Ohmura T, Nishizaki Y. Allergen-specific human T cell clones produce IL-5 upon stimulation with Th1 cytokine, IL-2. Int Arch Allergy Immunol. 107:1995;220-222.
28. Nakata A, Kaminuma O, Mori A, Ogawa K, Kikkawa H, Naito K. Evidence that cyclosporin A and dexamethasone inhibit allergic airway eosinophilic inflammation via suppression of interleukin-5 synthesis by T cells. Br J Pharmacol. 124:1998;1425-1432.
29. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. J Immunol. 146:1992;374-377.
30. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol. 10:1994;587-593.
31. Azzawi M, Bradley BO, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis. 142:1990;1410-1413.
32. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis. 140:1989;1745-1753.
33. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol. 85:1990;422-436.
34. Corrigan CT, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today. 13:1992;501-506.
35. Chand N, Harrison JE, Rooney S, Pillar J, Jakubicki R, Nolan K. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur J Pharmacol. 211:1992;121-123.
36. Van Oosterhout, Ladenius ARC, Savelkoul HFJ, Ark IV, Delsman KC, Nijkamp FP. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis. 147:1993;548-552.
37. Robinson DS, Ying S, Bentley AM, Meng Q, North J, Durham SR. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol. 92:1993;397-402.
38. + T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol. 92:1993;313-324.
39. Humbert M, Corrigan CJ, Kimmitt P, Till SJ, Kay AB, Durham SR. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med. 156:1997;704-708.
40. Krishnaswamy G, Liu MC, Su S, Kumai M, Xiao H, Marsh DG. Analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma. Am J Respir Cell Mol Biol. 9:1993;279-286.
41. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med. 173:1991;775-778.
42. Mizoguchi M, Kawaguchi K, Ohsuga Y, Ikari Y, Yanagawa A, Mizushima Y. Cyclosporin ointment for psoriasis and atopic dermatitis. Lancet. 339:1120;1120.
43. Okudaira H, Mori A, Suko M, Etoh T, Nakagawa H, Ito K. Enhanced production and gene expression of IL-5 in bronchial asthma: management of atopic diseases with agents that downregulate IL-5 gene transcription. ACI News. 6:1994;19-25.
44. Mori A, Suko M, Tsuruoka N, Etoh M, Nakagawa H, Kaminuma O. Atopic diseases and eosinophilic inflammation: possible management with downregulation of IL-5 gene transcription. Environmental Dermatology. 1:1994;42-54.
45. Mori A, Suko M, Kaminuma O, Nishizaki Y, Mikami T, Ohmura T. A critical role of IL-2 for the production and gene transcription of IL-5 in allergen-specific human T cell clones. Int Immunol. 8:1996;1889-1895.
46. Mori A, Inoue S, Mikami T, Kaminuma O, Ohmura T, Nishizaki Y. Analysis of human IL-5 gene transcription by T cell clones and hybridomas. Int Arch Allergy Immunol. 107:1995;366-367.
47. Nagai H, Yamaguchi S, Tanaka H, Inagaki N. Effect of some immunosuppressors on allergic bronchial inflammation and airway hyperresponsiveness in mice. Int Arch Allergy Immunol. 108:1995;189-195.
48. De Bie JJ, Hessel EM, Van Ark, Van Esch, Hofman G, Nijkamp FP. Effect of dexamethasone and endogenous corticosterone on airway hyperresponsiveness and eosinophilia in the mouse. Br J Pharmacol. 119:1996;1484-1490.
49. Eum SY, Creminon C, Haile S, Lefort J, Vargaftig BB. Inhibition of airways inflammation by dexamethasone is followed by reduced bronchial hyperreactivity in BP2 mice. Clin Exp Allergy. 26:1996;971-979.